Andere talen Mayne Pharma Group Limited

Aandelen

MYX

AU000000MYX0

Beurs gesloten - Australian S.E. Andere beurzen 08:10:45 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,66 ^AUD	-1,33%		-5,67%	+8,29%

08/03	Lagere omzet Mithra ondanks hogere productomzet	AM
05/03	Mithra zet zichzelf in de etalage	AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

MAYNE PHARMA REPORTS 1H FY24 RESULTS WITH A 43% INCREASE IN REVENUE TO A$188 MILLION AND $8 MILLION UNDERLYING EBITDA	27/02
Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	26/02
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	25/02
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	16/02
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	15/02
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference	29/12
Mayne Pharma Group Limited Approves Election of Anne Lockwood	30/11
Mithra Pharmaceuticals Obtains US Patent for Contraceptive Pill	07/11
Mayne Pharma Gets Additional US Patent for Contraceptive	06/11
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	03/11
MAYNE PHARMA PROVIDES UPDATE ON FIRST QUARTER 2024 TRADING AND OUTLOOK	19-10-23
Mayne Pharma Acquires Dermatological Medication	26-09-23
Mayne Pharma Group Limited completed the acquisition of Assets Related To RHOFADE® (Oxymetazoline Hydrochloride) Cream 1% from EPI Health, LLC.	25-09-23
Mayne Pharma Group Limited agreed to acquire Assets Related To RHOFADE® (Oxymetazoline Hydrochloride) Cream 1% from EPI Health, LLC for $8 million.	07-09-23
Australian Shares Rebound Ahead of Central Bank Policy Meeting	04-09-23
Mayne Pharma Group Purchasing Global Rights to Topical Treatment RHOFADE	04-09-23
Tranche Update on Mayne Pharma Group Limited's Equity Buyback Plan announced on May 10, 2023.	31-08-23
Mayne Pharma Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Lupin Gets US FDA Nod for Doxycycline Hyclate Delayed-Release Tablets	15-08-23
Mayne Pharma Group Limited Announces Retirement of Carolyn Myers from the Board At the End of July 2023	27-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Mayne Pharma Group Limited

Aandelen

MYX

AU000000MYX0

Andere talen

Filters